Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M F Piercey

Showing results (51-60 of 82) with videos related to

Pageof 9
Sort By:
Brain Research|April 6, 1981
Behavioral evidence that substance P may be a spinal cord sensory neurotransmitterM F Piercey, P J Dobry, L A Schroeder, et al.
Brain Research|October 20, 1987
Reversal of scopolamine-induced amnesia and alterations in energy metabolism by the nootropic piracetam: implications regarding identification of brain structures involved in consolidation of memory tracesM F Piercey, G D Vogelsang, S R Franklin, et al.
Science (New York, N.Y.)|December 18, 1981
Sensory and motor functions of spinal cord substance PM F Piercey, L A Schroeder, K Folkers, et al.
Brain Research|October 15, 1986
Analgesic activities of spinal cord substance P antagonists implicate substance P as a neurotransmitter of pain sensationM F Piercey, M W Moon, J R Blinn, et al.
Regulatory Peptides|May 1, 1982
Use of substance P fragments to differentiate substance P receptors of different tissuesM F Piercey, P J Dobry, F J Einspahr, et al.
Journal of the Neurological Sciences|May 1, 1994
Metabolic effects of scopolamine and physostigmine in human brain measured by positron emission tomographyJ Blin, M F Piercey, M E Giuffra, et al.
Life Sciences|September 20, 1982
U-50488H, a pure kappa receptor agonist with spinal analgesic loci in the mouseM F Piercey, R A Lahti, L A Schroeder, et al.
Molecular Pharmacology|September 1, 1992
Intrinsic activity determinations at the dopamine D2 guanine nucleotide-binding protein-coupled receptor: utilization of receptor state binding affinitiesR A Lahti, L M Figur, M F Piercey, et al.
Life Sciences|January 1, 1992
Effect of the anticonvulsant U-54494A on cortical neuron excitability: comparison to the kappa agonist U-50488HM C Ochoa, G D Vogelsang, J T Lum, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 1, 1991
Effects of the partial dopamine receptor agonists SDZ 208-911, SDZ 208-912 and terguride on central monoamine receptors. A behavioral, biochemical and electrophysiological studyK Svensson, A Ekman, M F Piercey, et al.
Pageof 9

Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
Brain Research|April 6, 1981
Behavioral evidence that substance P may be a spinal cord sensory neurotransmitterM F Piercey, P J Dobry, L A Schroeder, et al.
Brain Research|October 20, 1987
Reversal of scopolamine-induced amnesia and alterations in energy metabolism by the nootropic piracetam: implications regarding identification of brain structures involved in consolidation of memory tracesM F Piercey, G D Vogelsang, S R Franklin, et al.
Science (New York, N.Y.)|December 18, 1981
Sensory and motor functions of spinal cord substance PM F Piercey, L A Schroeder, K Folkers, et al.
Brain Research|October 15, 1986
Analgesic activities of spinal cord substance P antagonists implicate substance P as a neurotransmitter of pain sensationM F Piercey, M W Moon, J R Blinn, et al.
Regulatory Peptides|May 1, 1982
Use of substance P fragments to differentiate substance P receptors of different tissuesM F Piercey, P J Dobry, F J Einspahr, et al.
Journal of the Neurological Sciences|May 1, 1994
Metabolic effects of scopolamine and physostigmine in human brain measured by positron emission tomographyJ Blin, M F Piercey, M E Giuffra, et al.
Life Sciences|September 20, 1982
U-50488H, a pure kappa receptor agonist with spinal analgesic loci in the mouseM F Piercey, R A Lahti, L A Schroeder, et al.
Molecular Pharmacology|September 1, 1992
Intrinsic activity determinations at the dopamine D2 guanine nucleotide-binding protein-coupled receptor: utilization of receptor state binding affinitiesR A Lahti, L M Figur, M F Piercey, et al.
Life Sciences|January 1, 1992
Effect of the anticonvulsant U-54494A on cortical neuron excitability: comparison to the kappa agonist U-50488HM C Ochoa, G D Vogelsang, J T Lum, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 1, 1991
Effects of the partial dopamine receptor agonists SDZ 208-911, SDZ 208-912 and terguride on central monoamine receptors. A behavioral, biochemical and electrophysiological studyK Svensson, A Ekman, M F Piercey, et al.
Pageof 9